Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease

Archives of Neurology

Volumn 57, Issue 7, 2000, Pages 983-988

  Molinuevo, Jose L ^a   Valldeoriola, Francesc ^a   Tolosa, Edaardo ^a   Rumiá, Jordi ^a   Valls Solé, Josep ^a   Roldan, Héctor ^a   Ferrer, Enric ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BRADYKINESIA; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; DRUG WITHDRAWAL; DYSKINESIA; FEMALE; HUMAN; MALE; MUSCLE RIGIDITY; PARKINSON DISEASE; PRIORITY JOURNAL; SAFETY; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME; TREMOR;

EID: 0033936304     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.57.7.983     Document Type: Article

References (41)

1. Laitinen LV, Eergenheim AT, Hariz Ml. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg. 1992:76:53-61.
2. Lozano AM, Lang AE, Galvez-Jimenez N, et al. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet. 1995;346:1383-1387.
3. Dogali M, Fazzini E, Kolodny E, et al. Stereotactic ventral pallidotomy for Parkinson's disease, neurology. 1995;45:753-761.
4. Baron MS, Vitek JL, Bakay RAE, et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol. 1996;40:355-366.
5. Siegfried J. Therapeutical neurostimulation: indications reconsidered. Acta Neurochir. 1991;52:112-117.
6. Benabid AL, Pollack P, Gervanson G, et al. Long term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet. 1991; 337:401-406.
7. Limousin P, Pollack P, Benazzouz A. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet. 1995:345:91-95.
8. Kumar R, Lozano AM, Kim YJ, et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology. 1998;51: 850-855.
9. Pollak P, Benabid AL, Jervasson CL, et al. Long-term effects of chronic stimulation of ventral intermediate thalamic nucleous in different types of tremor. Adv Neurol. 1993;60:408-413.
10. Siegfried J, Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery. 1994;35:1126-1130.
11. Gross C, Rougier A, Guehl D, Boraud T, Julien J, Bioulac B. High-frequency stimulation of the globus pallidus internalis in Parkinson's disease: a study of seven cases. J Neurosurg. 1997;87:491-498.
12. Tronnier VM, Fogel W, Kronenbuerger M, Steinvorth S. Pallidal stimulation: an alternative to pallidotomy? J Neurosurg. 1997;87:700-705.
13. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsoniam by lesions of the subthalamic nucleus. Science. 1990;249:1436-1438.
14. Aziz TZ, Peggs D, Agarwal E, Sambrook MA, Crossman AR. Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate. Br J Neurosurg. 1992;6:575-582.
15. Guridi J, Herrero MT, Luquin R, et al. Subthalamotomy in parkinsonian monkeys: behavioural and biochemical analysis. Brain. 1996;119:1717-1727.
16. Benazzouz A, Gross C, Feger J, Boraud T, Bioulac B. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur J Neurosci. 1993;5:382-389.
17. Limousin P, Krack P, Pollack P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 1998;339:1105-1111.
18. Krack P, Pollak P, Limousin P, et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain. 1998;121:451-457.
19. Moro E, Scerrati M, Romito LMA, Roselli R, Tonali P, Albanese A. Chronic sub-thalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology. 1999:53:85-90.
20. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181-184.
21. Langston JW, Widner H, Goetz CG, et al. Core Assessment Program for Intracerebral Transplantations (CAPIT). MovDisord. 1992:7:2-13.
22. Fahn S, Elton RL, members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Golgstein M, eds. Recent Developments in Parkinson's Disease. Vol 2. Florham Park, NJ: Macmillan Health Care Information; 1987:153-164.
23. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427-442.
24. Schwab RS, England RC. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJ, Donaldson IML, eds. Parkinson's Disease. Edinburgh, Scotland: ESS Livingstone; 1969:152-157.
25. Sweet RA, DeSensi EG, Zubenko GS. Reliability and applicability of movement disorder rating scales in the elderly. J Neuropsychiatry Clin Neurosci. 1993:5:56-60.
26. Schaltenbrandt G, Wahren W. Atlas for Stereotaxy of the Human Brain. Stuttgart, Germany: Thieme; 1977.
27. Hutchison WD, Allan RJ, Opitz H, et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's. disease. Ann Neurol. 1998;44: 622-628.
28. Wichmann T, Bergman H, DeLong MR. The primate subthalamic nucleus, I: functional properties in intact animals. J Neurophys. 1994;72:494-506.
29. Wichmann T, Bergman H, DeLong MR. The primate subthalamic nucleus, II: neuronal activity in the MPTP model of parkinsonism. J Neurophys. 1994:72:507520.
30. Bejjani BP, Damier P, Arnulf I, et al. Transient acute depression induced by highfrequency deep brain stimulation. N Engl J Med. 1999:340:1476-1480.
31. Fraix V, Pollak P, Van Blercom N, et al. The effect of subthalamic nucleus stimulation on levodopa induced dyskinesias in patients with Parkinson's disease [abstract]. Neurology. 1999;52(suppl 2):A403.
32. Wichmann T, Bergman H, DeLong MR. The primate subthalamic nucleus. III: changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. J Neurophys. 1994;72:521-530.
33. Ceballos-Baumann AO, Boecker H, Bartenstein P, et al. A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease. Arch Neurol. 1999:56:997-1003.
34. Martin JP. Hemichorea resulting from a focal lesion of the brain (the syndrome of Luys). Brain. 1927:50:637-651.
35. Limousin P, Pollak P, Hoffmann D, Benazzouz A, Perret JE, Benabid AL Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients. Mov Disord. 1996:11:231-235.
36. Krack P, Limousin P, Benabid AL, Pollak P. Chronic Stimulation of the subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease. Lancet, 1997:350:1676.
37. Krack P, Pollak P, Limousin P, Benazzouz A, Deuschl G, Benabid AL. From off period dystonia to peak-dose chorea: the clinical spectrum of varying subthalamic nucleus activity. Brain. 1999;122:1133-1146.
38. Figueiras-Méndez R, Marin Zarza F, Molina JA, et al. Subthalamic nucleus stimulation improves directly t-dopa induced dyskinesias in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999:66:549-550.
39. Piallat B, Benazzouz A, Benabid AL. Subthalamic nucleus in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies. Eur J Neurosci. 1996:8:14081414.
40. Piallat B, Benazzouz A, Benabid AL. Neuroprotective effect of chronic inactivation of the subthalamic nucleus in a rat model of Parkinson's disease. J Neural Transm Suppl. 1999:55:71-77.
41. Molinuevo JL, Valldeoriola F, Rumià J, et al. Contribution of neurophysiological guidance to stereotactic posteroventral pallidotomy for Parkinson's disease. Acta Neurochir. 1999;141:1195-1201.